Edesa Biotech Inc Stock Performance
as on September 17, 2025 at 1:25 am IST
Day's Low
$2.42$2.46
1.63%
Downside
52 Week's Low
52 Week's High
$1.55$536.99%
Downside
103.25%
Upside
Edesa Biotech Inc share price movements today
- Previous Close
- $2.40
- Open
- $2.46
- Volume
- 53.6K
- Day's Low - High
- $2.42 - $2.46
- 52 Week Low - High
- $1.55 - $5
Edesa Biotech Inc Historical Returns
- 1 Month Return
- + 10.07 %
- 3 Month Return
- + 22.39 %
- 1 Year Return
- -42.32 %
- 3 Year Return
- -79.33 %
- 5 Year Return
- -95.24 %
Edesa Biotech Inc Stock Fundamentals & Key Indicators
Check Edesa Biotech Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$18.1M
EPS (TTM)
-1.145
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-6.4M
Revenue (TTM)
500.0
Profit Margin
0.00%
Return On Equity TTM
0.00%
Edesa Biotech Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Edesa Biotech Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $18.1M | -95.24% | NA | 0.00% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
| BUY | $59.6B | 1.78% | 14.1 | 31.37% |
Stock Returns calculator for Edesa Biotech Inc Stock including INR - Dollar returns
The Edesa Biotech Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Edesa Biotech Inc investment value today
Current value as on today
₹62,614
Returns
Returns from Edesa Biotech Inc Stock
Dollar Returns*
₹4,867 (+4.87%)
Analyst Recommendation on Edesa Biotech Inc Stock
Based on 8 analysts
87.50%
Buy
12.50%
Hold
0.00%
Sell
Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Edesa Biotech Inc. Average target price of $10.33
Edesa Biotech Inc Share Price Target
Get share price movements and forecasts by analysts on Edesa Biotech Inc.
What analysts predicted
76.19%UPSIDE
Target Price
$10.33
Current Price
$2.46
Analyzed by
8 Analysts
Target
$10.33
Edesa Biotech Inc target price $10.33, a slight upside of 76.19% compared to current price of $2.46. According to 8 analysts rating.
Edesa Biotech Inc Stock's Interest Amongst Investors
Search interest for Edesa Biotech Inc Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:133% versus previous 30 day period
Edesa Biotech Inc Quarterly Profit & Loss
All numbers in Millions USD
Edesa Biotech Inc Annual Profit & Loss
All numbers in Millions USD
Edesa Biotech Inc Quarterly Cash Flow
All numbers in Millions USD
Edesa Biotech Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Edesa Biotech Inc
Insights on Edesa Biotech Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
NO EFFECTAgainst Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 195.8%
- NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.1% return, outperforming this stock by 110.4%
NEGATIVE IMPACTPrice Dip
In the last 1 year, EDSA stock has moved down by -42.3%
About Edesa Biotech Inc
| Organisation | Edesa Biotech Inc |
| Headquarters | 100 Spy Court, Markham, ON, Canada, L3R 5H6 |
| Industry | Biotechnology |
| CEO | Dr. Pardeep Nijhawan FRCPC, M.D. |
| E-voting on shares | Click here to vote |
Key Management of Edesa Biotech Inc
Name | Title |
|---|---|
Dr. Pardeep Nijhawan FRCPC, M.D. | CEO, Company Secretary & Director |
Dr. Michael J. Brooks M.B.A., Ph.D. | President |
Mr. Peter John Weiler M.B.A, M.Sc. | Chief Financial Officer |
FAQs
What is Edesa Biotech Inc share price today?
Edesa Biotech Inc share price today is $2.46 as on at the close of the market. Edesa Biotech Inc share today touched a day high of $2.46 and a low of $2.42.
What is the 52 week high and 52 week low for Edesa Biotech Inc share?
Edesa Biotech Inc share touched a 52 week high of $5 on and a 52 week low of $1.55 on . Edesa Biotech Inc stock price today i.e. is closed at $2.46,which is 50.80% down from its 52 week high and 58.71% up from its 52 week low.
What is Edesa Biotech Inc's market capitalisation today?
Edesa Biotech Inc market capitalisation is $0.00T as on .
How to invest in Edesa Biotech Inc Stock (EDSA) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Edesa Biotech Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Edesa Biotech Inc Shares that will get you 0.6098 shares as per Edesa Biotech Inc share price of $2.46 per share as on September 17, 2025 at 1:25 am IST.
What is the minimum amount required to buy Edesa Biotech Inc Stock (EDSA) from India?
Indian investors can start investing in Edesa Biotech Inc (EDSA) shares with as little as ₹88.042 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Edesa Biotech Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Edesa Biotech Inc share’s latest price of $2.46 as on September 17, 2025 at 1:25 am IST, you will get 4.0650 shares of Edesa Biotech Inc. Learn more about
fractional shares .
What are the returns that Edesa Biotech Inc has given to Indian investors in the last 5 years?
Edesa Biotech Inc stock has given -95.24% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?